Comunicati Stampa
Salute e Benessere

Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer

Coronado Research CEO, Andrew MacGarvey said "I am delighted to add Jen to the Coronado team. As Chief Scientific Officer, she will ensure that our service offering remains true to our vision. She brings significant experience in novel methodologies, something that is key to evolving clinical trials. Jen will combine high-calibre research with commercial understanding to build out our service offerings to accelerate drug development and ensure new treatments better meet market needs." Coronado...
LONDON, (informazione.it - comunicati stampa - salute e benessere)

 said "I am delighted to add Jen to the Coronado team. As Chief Scientific Officer, she will ensure that our service offering remains true to our vision. She brings significant experience in novel methodologies, something that is key to evolving clinical trials. Jen will combine high-calibre research with commercial understanding to build out our service offerings to accelerate drug development and ensure new treatments better meet market needs."

 commented, "Andrew and I have enjoyed working together before, so I jumped at the chance to work with him again to build a data-driven company that will transform the drug development process. I have always been an advocate for innovation and challenging the status quo where it is no longer fit for purpose. I am very excited to be given the opportunity to make a difference in the industry with Coronado Research."

She added, "The clinical trial space is changing with the adoption of Artificial Intelligence and machine learning technologies, but the importance of the human-in-the-loop to design, develop, and implement them cannot be understated. As regulators also become more open to innovative and complex trial designs, Coronado will work with Sponsors to ensure that they are extracting the most value from their data, all the way from Regulatory Strategy through to Market Access."

Coronado Research is a consultancy-led, professional services organisation, which provides support to pharmaceutical, biotechnology, and medical device companies. Our objective is to optimise the clinical development process by leveraging all the data available using AI, ML, and leading technologies.

Our practices cover Regulatory Strategy, Advanced Analytics, Market Access and Health Economics, and Technology. Our teams work with customers to "join-the-dots" between these disciplines to ensure treatments are developed with the end in mind and better match market needs.

For further information please contact: datadriven@coronado-research.com

Website: www.coronado-research.com

View original content: https://www.prnewswire.co.uk/news-releases/coronado-research-limited-announce-appointment-of-professor-jennifer-visser-rogers-as-chief-scientific-officer-302285827.html

Ufficio Stampa
 PR Newswire (Leggi tutti i comunicati)
209 - 215 Blackfriars Road
LONDON United Kingdom
Allegati
Non disponibili